Potential Carestream buyers dwindle to two bidders

| April 26, 2013 | Health Imaging | Economics

It appears there are just two remaining potential bidders vying for control of Carestream Health, according to a Reuters report.

Bain Capital and Thomas H. Lee Partners are the final two firms in the running after others withdrew from the process to acquire Carestream from Onex, according to the report. Once hoping to sell Carestream for $3.5 billion, Onex has now valued the medical imaging company at no more than $2.5 billion, according to Reuters. Read more at the link below:

Bidders for Carestream down to Bain, THL -sources

Around the web

Cardiovascular Business

Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business

‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business

FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.

Potential Carestream buyers dwindle to two bidders

Related Content

Around the web